Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffei

23 Mar 2021

Abstract excerpt

In vitro antifungal susceptibility profiling of 32 clinical and environmental Talaromyces marneffei isolates recovered from southern China was performed against olorofim and 7 other systemic antifungals, including amphotericin B, 5-flucytosine, posaconazole, voriconazole, caspofungin, and terbinafine, using CLSI methodology. In comparison, olorofim was the most active antifungal agent against both mold and yeast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Fungal Infections and Studies
Share to Infectious Diseases and Mycology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33753341
DOI: 10.1128/aac.00256-21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffeiPMID 33753341Read ↗

Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatus Isolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in ChinaSemantic proximity Read ↗

Characterization of Clinical Isolates of Talaromyces marneffei and Related Species, California, USASemantic proximity Read ↗

Species distribution and antifungal susceptibilities of clinical isolates of Penicillium and Talaromyces species in ChinaSemantic proximity Read ↗

Phylogenetic Insights into Antifungal Susceptibility: Comparing Environmental and Clinical <i>Scedosporium</i> and <i>Lomentospora</i> Isolates from TaiwanSemantic proximity Read ↗

Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).Semantic proximity Read ↗

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICsSemantic proximity Read ↗

Novel Antifungals and <em>Aspergillus</em> Section <em>Terrei</em> with Potpourri Susceptibility Profiles to Conventional AntifungalsSemantic proximity Read ↗

Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofimSemantic proximity Read ↗

A novel Erg3 T208I substitution mediates triazole resistance in Talaromyces marneffei clinical isolates from HIV/AIDS patients in southern ChinaSemantic proximity Read ↗

Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complexSemantic proximity Read ↗

Association between genomic single nucleotide polymorphisms and susceptibility of Talaromyces marneffei.Semantic proximity Read ↗

Susceptibility of Filamentous Fungi to Voriconazole in Malaysia Tested by Sensititre YeastOne and CLSI Microdilution MethodsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.